References

Practice Bulletin No. 180: Gestational Diabetes Mellitus. Obstet Gynecol. 2017; 130:(1)e17-e37 https://doi.org/10.1097/AOG.0000000000002159

13. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018; 41:S137-S143 https://doi.org/10.2337/dc18-S013

Balsells M, García-Patterson A, Solà I, Roqué M, Gich I, Corcoy R. Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis. BMJ. 2015; 350:(14) https://doi.org/10.1136/bmj.h102

Brown SC, Kyne-Grzebalski D, Mwangi B, Taylor R. Effect of management policy upon 120 Type 1 diabetic pregnancies: policy decisions in practice. Diabet Med. 1999; 16:(7)573-578 https://doi.org/10.1046/j.1464-5491.1999.00124.x

Catalano PM, Huston L, Amini SB, Kalhan SC. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol. 1999; 180:(4)903-916 https://doi.org/10.1016/S0002-9378(99)70662-9

Caughey AB, Turrentine M. ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus. Obstet Gynecol. 2018; 131:(2)e49-e64 https://doi.org/10.1097/AOG.0000000000002501

Confidential Enquiry into Maternal and Child Health: Pregnancy in Women with Type 1 and Type 2 Diabetes in 2002–03, England, Wales and Northern Ireland.London: CEMACH; 2005

Crowther CA, Hiller JE, Moss JR Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005; 352:(24)2477-2486 https://doi.org/10.1056/NEJMoa042973

Diabetes in Pregnancy Advisory Group. Type 1 diabetes and pregnancy: ‘Sick Days’—what to do if unwell. 2010. http://www.perinatal.nhs.uk/diabetes/projects/leaflets/Sick_Days_Type1.pdf (accessed 11 June 2019)

Ehrenberg HM, Mercer BM, Catalano PM. The influence of obesity and diabetes on the prevalence of macrosomia. Am J Obstet Gynecol. 2004; 191:(3)964-968 https://doi.org/10.1016/j.ajog.2004.05.052

Evers IM, de Valk HW, Visser GHA. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ. 2004; 328:(7445)915-918 https://doi.org/10.1136/bmj.38043.583160.EE

García-Patterson A, Gich I, Amini SB, Catalano PM, de Leiva A, Corcoy R. Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: three changes of direction. Diabetologia. 2010; 53:(3)446-451 https://doi.org/10.1007/s00125-009-1633-z

Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014; 103:(2)137-149 https://doi.org/10.1016/j.diabres.2013.11.002

Metzger BE, Lowe LP Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008; 358:(19)1991-2002 https://doi.org/10.1056/NEJMoa0707943

International Diabetes Foundation School of Diabetes. Gestational Diabetes Mellitus: A Growing Concern. 2019. https://www.idfdiabeteschool.org/Resources/NewsLetter/Documents/IDF_SOD_NL01_Ver1.02_SP.pdf (accessed 11 June 2019)

Management of glycaemic control in pregnant women with diabetes on obstetric wards and delivery units.London: RCOG; 2017

Kc K, Shakya S, Zhang H. Gestational diabetes mellitus and macrosomia: a literature review. Ann Nutr Metab. 2015; 66:(2)14-20 https://doi.org/10.1159/000371628

McCance DR. Pregnancy and diabetes. Best Pract Res Clin Endocrinol Metab. 2011; 25:(6)945-958 https://doi.org/10.1016/j.beem.2011.07.009

Metzger BE, Gabbe SG, Persson B International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010; 33:(3)676-682 https://doi.org/10.2337/dc09-1848

Hypertension in Pregnancy: diagnosis and management [CG70].London: NICE; 2011

Diabetes in pregnancy: management from preconception to the postnatal period [NG3].London: NICE; 2015a

Preterm Labour and Birth [NG25].London: NICE; 2015b

National Institutes of Health consensus development conference statement: diagnosing gestational diabetes mellitus, March 4-6, 2013. Obstet Gynecol. 2013; 122:(2 Pt 1)358-69 https://doi.org/10.1097/AOG.0b013e31829c3e64

Padmanabhan S, McLean M, Cheung NW. Falling insulin requirements are associated with adverse obstetric outcomes in women with preexisting diabetes. Diabetes Care. 2014; 37:(10)2685-2692 https://doi.org/10.2337/dc14-0506

Rowan JA, Hague WM, Gao W, Battin MR, Moore MP Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008; 358:(19)2003-2015 https://doi.org/10.1056/NEJMoa0707193

Scholtens DM, Kuang A, Lowe LP Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Glycemia and Childhood Glucose Metabolism. Diabetes Care. 2019; 42:(3)381-392 https://doi.org/10.2337/dc18-2021

Diabetes in pregnancy: a practical guide for midwives

02 July 2019
12 min read
Volume 27 · Issue 7

Abstract

Diabetes is a growing concern. With the rising incidence of obesity in the younger people, the incidence of diabetes has also increased. This has resulted in more women of childbearing age attending antenatal clinic with a diagnosis of either pre-existing or gestational diabetes. Management of these women is vital to avoid complications in both the mother and the child during pregnancy and childbirth. This article aims to provide a concise guide to the management of diabetes in pregnancy for midwives, who are often the first point of contact for these women.

The incidence of diabetes mellitus is increasing, alongside the increased prevalence of obesity, sedentary lifestyle, older age at conception and younger age at onset of type 2 diabetes, meaning that more women are pregnant and have diabetes (McCance et al, 2011; National Institutes of Health, 2013; Guariguata et al, 2014).

As midwives are often the first point of contact for women during pregnancy, the following article aims to provide a concise, practical review, from the first visit to the postnatal period. The article is aimed at both community and hospital-based midwives and gives an overview of care with relevant supporting evidence.

Wherever possible, the authors recommend referring to local guidelines for specifics of care. Until 2009, glycated haemoglobin (HbA1c) was solely reported in Diabetes Control and Complications Trial units (%). To standardise reporting across the world, the International Federation of Clinical Chemistry units (which report HbA1c as mmol/mol) were introduced and adopted in the UK in 2009. HbA1c is reported in both formats throughout this article. Women who have type 1 or type 2 diabetes before pregnancy are referred to as ‘pre-existing diabetes’, but distinguished where necessary.

Register now to continue reading

Thank you for visiting British Journal of Midwifery and reading some of our peer-reviewed resources for midwives. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to our clinical or professional articles

  • Unlimited access to the latest news, blogs and video content

  • Monthly email newsletter